Use of a multi-species probiotic Probiz for the prevention of antibiotic-associated diarrhea

The use of antibacterial drugs for the treatment of acute respiratory pathology promotes the development of dysbiosis in some patients, negatively affects the state of the intestine. The use of the probiotic complex Probiz, which contains Saccharomyces boulardii, lacto- and bifidobacteria, from the first days of therapy with antibacterial drugs, significantly reduces the manifestations of antibiotic-associated diarrhea in children and positively effects on the intestinal microbiota.